Urological Cancers

ISBN-13: 9781852339111 / Angielski / Twarda / 2005 / 360 str.

Jonathan Waxman

Opis

Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest too has grown from the pharmaceutical industry, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations. This book outlines developments in all areas of urological cancer, bringing together summaries of clinical and molecular advances in one volume, which will be invaluable to urologists and oncologists.

Recenzje

From the reviews:

"This is an impressive text set out in such a manner that the major malignancies of urological cancers are sequential. … The format is user friendly and allows the reader to find specific information in an ordered fashion. … The conclusion of each chapter is succinct and informative … . Useful tables in an easily readable format are contained through the text … . this is an informative and clinically up-to-date text, which should appeal to medical staff, the urological nursing group … . " (Mary Leahy, CancerForum, Vol. 30 (3), November, 2006)

Spis treści

Part 1 Prostate Cancer 1 The Molecular Biology of Prostate Cancer Sarah Ngan and Jonathan Waxman 2 Familial Prostate Cancer Rosalind A. Eeles and Sashi S. Kommu 3 Screening for Prostate Cancer Joshua Phillips and Freddie C. Hamdy 4 Diet and Prostate Cancer Danish Mazhar 5 Radical Radiotherapy for Prostate Cancer Mererid Evans and Malcolm D. Mason 6 Prostate Cancer: Immediate vs Deferred Treatment Mark A. Underwood and David Kirk 7 Surgical Treatment of Prostate Cancer Mark R. Feneley and Roger S. Kirby 8 Hormone Therapy for Prostate Cancer Gairin J. Dancey and Jonathan Waxman 9 Chemotherapy in Prostate Cancer Srikala S. Sridhar and Malcolm J. Moore 10 Proteomic Approaches to Problem Solving in Prostate Cancer Simon C. Gamble 11 Gene Therapy for Prostate Cancer Roopinder Gillmore and Danish Mazhar Part 2 Bladder Cancer 12 Molecular Biology of Bladder Cancer Margaret A. Knowles 13 Treatment Options in Superficial (pTa/pT1/CIS) Bladder Cancer Jeremy L. Ockrim and Paul D. Abel 14 Chemotherapy for Bladder Cancer Matthew D. Galsky and Dean F. Bajorin 15 Gene Therapy of Urothelial Malignancy Sunjay Jain and J. Kilian Mellon Part 3 Kidney Cancer 16 Molecular Biology of Kidney Cancer Jeffrey M. Holzbeierlein and J. Brantley Thrasher 17 Cytokine and Angiogenesis Inhibitors Simon Chowdhury, Martin Gore and Timothy G. Eisen 18. Novel Therapies for Renal Cell Cancer Mayer N. Fishman Part 4 Testicular Cancer 19 Genetics and Biology of Adult Male Germ Cell Tumors Jane Houldsworth, George J. Bosl and R. S. K. Chaganti 20 Chemotherapy for Testicular Cancer Thomas R. Geldart and Graham M. Mead 21 Surgery for Testicular Cancer Gillian L. Smith and Timothy J. Christmas 22 Pathobiological Basis of Treatment Strategies of Germ Cell Tumours J. Wolter Oosterhuis, Friedemann Honecker, Frank Mayer, Carsten Bokemeyer and L. H. J. Looijenga Part 5 Penile Cancer 23 A Scientific Understanding of the Development of Penile Tumours T. R. Leyshon Griffiths and J. Kilian Mellon 24 The Clinical Management of Penile Cancer Rajiv Sarin, Hemant B. Tongaonkar and Reena Engineer Part 6 Unusual Urological Tumours 25 Oncocytoma and Rare Renal Tumours Holger Moch 26 Small Cell Tumours, Lymphomas, Sertoli Cell and Leydig Cell Tumours of the Bladder, Prostate and Testis Chris M. Bacon, Alex Freeman

Blurb

Our understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest within the pharmaceutical industry has grown as well, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations.

This book outlines developments in all areas of urological cancer, bringing together, in one volume, summaries of clinical and molecular advances, which will be invaluable to urologists and oncologists.